Cupid Limited is stepping up its international manufacturing strategy with an ambitious South African expansion, securing in-principle approval from its Board of Directors to establish a manufacturing venture with a South African partner.

 

The proposed venture will create a locally based manufacturing facility for the manufacture, processing, testing, packaging, marketing and supply of male condoms and related products, strengthening Cupid’s presence in one of its strategically important international markets.

 

Under the proposed structure, Cupid Limited is expected to hold up to 49% of the equity, while the South African partner and/or qualifying local shareholders would hold at least 51% and retain control. The structure is designed to align with South Africa’s ownership, localisation, transformation, procurement and tender requirements.

 

Cupid’s proposed manufacturing venture comes as South Africa places growing emphasis on domestic manufacturing, local value addition and supply-chain resilience, particularly across public procurement and healthcare-related supply chains.

 

The company said the proposed facility is designed to support these priorities by creating local manufacturing capabilities, employment and skills development, technology transfer and greater local value addition.

 

Cupid already has an established presence in the South African market and has been supplying the country for several years. Through its existing local business arrangements, the company currently participates in the RT75-2025 five-year tender for male and female condoms.

 

A local manufacturing base could further strengthen Cupid’s long-term position in the market and potentially improve its ability to participate in future institutional and government procurement opportunities.

 

One of the key features of the proposed venture is its asset-light structure.

 

Cupid is expected to contribute its manufacturing and technical expertise, industry know-how, technology-transfer support, quality-control systems, training and other mutually agreed operational assistance.

 

The South African partner, meanwhile, is expected to arrange the capital expenditure required to establish and commission the facility, along with working capital and operating funding.

 

The structure effectively combines Cupid’s manufacturing capabilities and technical expertise with the local partner’s presence, ownership and funding support.

 

Cupid sees the proposed facility as more than a manufacturing base for the South African market.

 

The company expects the facility could become a local manufacturing and distribution platform for wider African expansion, supporting domestic institutional and government procurement while creating a potential base for serving neighbouring markets.

 

Subject to regulatory approvals, product registrations and commercial arrangements, the venture could eventually support additional international markets, including markets in the Western Hemisphere.

 

If successfully executed, the facility could evolve into a regional and global supply hub, giving Cupid another strategically located manufacturing base from which to serve international customers.

 

Aditya Kumar Halwasiya, Chairman & Managing Director, Cupid Limited, said: "South Africa is an important and strategically attractive market for Cupid Limited. The proposed venture combines our manufacturing expertise and established quality systems with strong local capabilities, while aligning with the country’s increasing focus on domestic manufacturing and local value addition. 

 

"We believe the initiative has the potential to create value for the South African healthcare ecosystem, local communities, business partners and our shareholders. A local manufacturing presence can also provide Cupid with a strong platform to participate more meaningfully in the wider African market and, over time, explore additional international opportunities.”